Compare TKLF & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKLF | BFRG |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 13.1M |
| IPO Year | 2022 | 2023 |
| Metric | TKLF | BFRG |
|---|---|---|
| Price | $2.50 | $1.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.7K | ★ 69.9K |
| Earning Date | 12-19-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $210,119,238.00 | $116,670.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.59 | ★ N/A |
| Revenue Growth | ★ 7.38 | N/A |
| 52 Week Low | $2.10 | $0.80 |
| 52 Week High | $4.32 | $4.84 |
| Indicator | TKLF | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 47.14 |
| Support Level | $2.35 | $1.10 |
| Resistance Level | $2.63 | $1.21 |
| Average True Range (ATR) | 0.22 | 0.08 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 59.70 | 53.23 |
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.